Abstract 6638: Real-World evidence of eflapegrastim (efla) usage in patients with gastrointestinal (GI) malignancies.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148867565
Cites:
Cited by:
Related to:
